Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

procter & gamble australia pty ltd - 45232 - dental material, desensitizing resin - tooth sensitivity relief strips. the sensitivity relief strips are intended to relieve dentinal sensitivity resulting from cold, heat, acids or sweets by providing physical protection against sensitivity caused by exposed dentinal tubules.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

procter & gamble australia pty ltd - 11168 - dentifrice - sensitivity shield toothpaste. a desensitising toothpaste to provide rapid relief from sensitivity and the pain associated with it by physically occluding the exposed dentinal tubules. to provide protection against painful sensitivity. to provide sustained sensitivity protection with continued use. to provide protection against root causes of future sensitivity: enamel erosion, exposed and recessed gums. to provide general hygienic and protection benefits associated with a dentifrice.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

procter & gamble australia pty ltd - 57958 - nasal irrigation cold intervention gel - intended to be used at the first symptoms of an emerging cold, or upon exposure to a cold, to reduce the ability of cold viruses to spread within the nasal cavity and fully infect the nasal epithelia. the device supplements the nose?s early physical defense mechanisms by physically removing extracellular cold viruses to slow the infection rate, therefore reducing symptom severity and allowing faster recovery. if used at the early stages of a cold before viruses have fully infected, it reduces the chances of a full-blown cold.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

procter & gamble australia pty ltd - 9951 - disinfectant, household/commercial grade - other therapeutic

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

procter & gamble (health & beauty care) ltd - oxymetazoline hydrochloride - spray - 500microgram/1ml

Estats Units - anglès - NLM (National Library of Medicine)

procter and gamble pharmaceuticals - dantrolene sodium (unii: 287m0347ev) (dantrolene - unii:f64qu97qcr) - injection - dantrium intravenous is indicated, along with appropriate supportive measures, for the management of the fulminant hypermetabolism of skeletal muscle characteristic of malignant hyperthermia crises in patients of all ages. dantrium intravenous should be administered by continuous rapid intravenous push as soon as the malignant hyperthermia reaction is recognized (i.e., tachycardia, tachypnea, central venous desaturation, hypercarbia, metabolic acidosis, skeletal muscle rigidity, increased utilization of anesthesia circuit carbon dioxide absorber, cyanosis and mottling of the skin, and, in many cases, fever). dantrium intravenous is also indicated preoperatively, and sometimes postoperatively, to prevent or attenuate the development of clinical and laboratory signs of malignant hyperthermia in individuals judged to be malignant hyperthermia susceptible. none.

Estats Units - anglès - NLM (National Library of Medicine)

procter & gamble manufactura s de rl de cv - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - cough suppressant/oral anesthetic temporarily relieves - cough due to a cold or inhaled irritants - minor sore throat

Estats Units - anglès - NLM (National Library of Medicine)

procter & gamble manufacturing company - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - - temporarily relieves common cold/flu symptoms: - nasal congestion - sinus congestion & pressure - cough due to minor throat & bronchial irritation - minor aches & pains - headache - fever - sore throat - reduces swelling of nasal passages - temporarily restores freer breathing through the nose - promotes nasal and/or sinus drainage - helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive. - with any other drug containing acetaminophen (prescription or nonprescription). if you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. - if you are now taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric or emotional conditions, or parkinson's disease), or for 2 weeks after stopping the maoi drug. if you do not know if your prescription drug contains an maoi, ask a doctor or pharmacist before taking this product. - liver disease - heart disease - high bloo

Canadà - anglès - Health Canada

procter & gamble pharmaceuticals canada inc - etidronate disodium - tablet - 200mg - etidronate disodium 200mg - miscellaneous therapeutic agents

Estats Units - anglès - NLM (National Library of Medicine)

procter & gamble pharmaceuticals - nitrofurantoin, macrocrystalline (unii: 927ah8112l) (nitrofurantoin - unii:927ah8112l) - capsule - 25 mg - macrodantin is specifically indicated for the treatment of urinary tract infections when due to susceptible strains of escherichia coli, enterococci, staphylococcus aureus , and certain susceptible strains of klebsiella and enterobacter species. nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. to reduce the development of drug-resistant bacteria and maintain the effectiveness of macrodantin and other antibacterial drugs, macrodantin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections. consequently, many patient